In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cordilox SR Drug Master File in Korea (Cordilox SR KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cordilox SR. The MFDS reviews the Cordilox SR KDMF as part of the drug registration process and uses the information provided in the Cordilox SR KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cordilox SR KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cordilox SR API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cordilox SR suppliers with KDMF on PharmaCompass.